The FTC imposed $12 million in penalties against Edwards Lifesciences and Genesis MedTech for structuring a deal to avoid HSR Act filing requirements.
| less than a minute read
A Cautionary Tale: FTC Obtains $12M Settlement for Hart-Scott-Rodino Act Failure to File Violation
Get in touch
Get in touch
Get in touch
Get in touch
Latest Insights
/Passle/6880addbd954bf894713d5af/SearchServiceImages/2026-07-15-18-35-01-645-6a57d2d5200f7fa481c64ccc.jpg)
/Passle/6880addbd954bf894713d5af/SearchServiceImages/2026-07-15-18-34-22-743-6a57d2ae200f7fa481c64c56.jpg)
/Passle/6880addbd954bf894713d5af/SearchServiceImages/2026-07-15-18-33-45-642-6a57d289a048136c79fe5438.jpg)
/Passle/6880addbd954bf894713d5af/SearchServiceImages/2026-07-15-18-31-37-581-6a57d209200f7fa481c64a3e.jpg)